Project Grant HT94252510250
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10468, USA
Similar Awards
The Bronx Veterans Medical Research Foundation, Inc. (BVMRF) was awarded a $339,855 federal Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports a 3-year research project titled "DATA SCIENCE APPROACHES TO PREDICT AND UNDERSTAND SIDE EFFECTS OF ANDROGEN DEPRIVATION THERAPY IN VETERANS WITH PROSTATE CANCER UNDERGOING LONG-TERM TREATMENT." This research aims to utilize data science methods to...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
This $495,024 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to examine the effects of psilocybin on brain mechanisms, cognition, and behavior in individuals with opioid use disorder. The 2-year project will prospectively assess 72 participants, randomized to receive either 25mg or 1mg (control) of psilocybin, and measure the impact on motivational, inhibitory, and...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) provides funding for a feasibility clinical trial of Psilocybin-Assisted Cognitive Behavioral Therapy (PA-CBT) for adults with major depressive disorder. The $236,250 award supports a two-phase study to refine and optimize the PA-CBT protocol and evaluate its feasibility, acceptability, and adherence....
Veterans Medical Research Foundation Of San Diego will use a $749,985 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to examine associations between traumatic brain injury history and other risk factors on Alzheimer's disease and related dementias in military veterans. As a non-profit organization, the Foundation will leverage its experience conducting medical research to enhance veteran health outcomes. For this award...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
The Lovelace Biomedical Research Institute will conduct a prospective observational study on the therapeutic and adverse effects of medical cannabis for chronic traumatic brain injury under a $1.5 million Project Grant from the Department of the Army Medical Command. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care through innovative solutions for battlefield medicine...
This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...